NCT03919890View on ClinicalTrials.gov

A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

August 23, 2019

Study Completion Date

August 23, 2019

Conditions
Venous Thromboembolism
Interventions
DRUG

ONO-7684

Single ascending doses for cohorts A1-A8 and multiple ascending doses cohorts B1-3

DRUG

ONO-7684 Placebo

Placebo comparator

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research (HMR), London

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY